Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Puente

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|September 12, 2008
[Current status of clinical pharmacokinetics in the Castile and Leon public hospital network]V Puente, R Almendros, J Prada
Acta Neurologica Scandinavica|June 16, 2006
Valproate-induced hyperammonemic encephalopathyN Segura-Bruna, A Rodriguez-Campello, V Puente, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 2, 2009
[Anaphylactic reaction to natalizumab]A Labajo Molpeceres, V Puente Lázaro, J Parda Lobato, et al.
Neurologia|March 13, 2016
Extrapyramidal syndrome with generalized chorea as an atypical presentation of progressive multifocal leukoencephalopathyC Avellaneda-Gómez, R Torres Iglesias, V Puente Periz, et al.
Neurologia|January 18, 2018
Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous communityD Santos-García, M J Catalán, V Puente, et al.
Parkinsonism & Related Disorders|September 19, 2009
Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of lifeV Puente, O De Fabregues, C Oliveras, et al.
Neurologia (Barcelona, Spain)|July 17, 2013
[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)]J Kulisevsky, M R Luquin, J M Arbelo, et al.
Neurologia (Barcelona, Spain)|July 25, 2013
Advanced Parkinson's disease: clinical characteristics and treatment. Part IIJ Kulisevsky, M R Luquin, J M Arbelo, et al.
Parkinsonism & Related Disorders|May 12, 2024
Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal studyA Cámara, Y Compta, M Baixauli, et al.
Parkinsonism & Related Disorders|August 15, 2024
Corrigendum to "Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study" [Park. Relat. Disord. (2024) 106993]A Cámara, Y Compta, M Baixauli, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|September 12, 2008
[Current status of clinical pharmacokinetics in the Castile and Leon public hospital network]V Puente, R Almendros, J Prada
Acta Neurologica Scandinavica|June 16, 2006
Valproate-induced hyperammonemic encephalopathyN Segura-Bruna, A Rodriguez-Campello, V Puente, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 2, 2009
[Anaphylactic reaction to natalizumab]A Labajo Molpeceres, V Puente Lázaro, J Parda Lobato, et al.
Neurologia|March 13, 2016
Extrapyramidal syndrome with generalized chorea as an atypical presentation of progressive multifocal leukoencephalopathyC Avellaneda-Gómez, R Torres Iglesias, V Puente Periz, et al.
Neurologia|January 18, 2018
Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous communityD Santos-García, M J Catalán, V Puente, et al.
Parkinsonism & Related Disorders|September 19, 2009
Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: impact on control of fluctuations and quality of lifeV Puente, O De Fabregues, C Oliveras, et al.
Neurologia (Barcelona, Spain)|July 17, 2013
[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)]J Kulisevsky, M R Luquin, J M Arbelo, et al.
Neurologia (Barcelona, Spain)|July 25, 2013
Advanced Parkinson's disease: clinical characteristics and treatment. Part IIJ Kulisevsky, M R Luquin, J M Arbelo, et al.
Parkinsonism & Related Disorders|May 12, 2024
Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal studyA Cámara, Y Compta, M Baixauli, et al.
Parkinsonism & Related Disorders|August 15, 2024
Corrigendum to "Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study" [Park. Relat. Disord. (2024) 106993]A Cámara, Y Compta, M Baixauli, et al.
Pageof 2